Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

V Colotta

Showing results (31-40 of 36) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 36 results.
Drug Design and Discovery|July 1, 1992
Tricyclic heteroaromatic systems. Synthesis and benzodiazepine binding activity of 1-substituted-3-methyl- and 3-phenylpyrazolo[4,5-c]quinolin-4-onesV Colotta, L Cecchi, F Melani, et al.
Farmaco (Societa Chimica Italiana : 1989)|June 26, 1998
Synthesis and A1 and A2A adenosine binding activity of some pyrano[2,3-c]pyrazol-4-onesV Colotta, D Catarzi, F Varano, et al.
Neuropharmacology|January 29, 2026
The potent and selective adenosine A<sub>2A</sub>R antagonists P400 and P625 protect against symptoms in autoimmune experimental encephalomyelitis by attenuating neuroinflammation and demyelinationM Morozzi, V Borgonetti, C Sasia, et al.
Journal of Chemical Information and Modeling|August 29, 2007
Tandem 3D-QSARs approach as a valuable tool to predict binding affinity data: design of new Gly/NMDA receptor antagonists as a key studyM Bacilieri, F Varano, F Deflorian, et al.
Journal of Cellular and Molecular Medicine|November 18, 2025
Protection From Demyelination by the Novel Adenosine Dual A<sub>2A</sub>/A<sub>2B</sub> Receptor Antagonist P626 in EAE and Cultured Oligodendrocyte Precursor CellsM Morozzi, F Cherchi, C Sasia, et al.
Neuropharmacology|October 20, 2025
Adenosine A<sub>2A</sub> receptor blockade promotes oligodendrocyte differentiation and myelination: Highlighting the potency of an edaravone-conjugated A<sub>2A</sub> receptor antagonistF Cherchi, L Frulloni, M Venturini, et al.
Pageof 4

Showing results (31-40 of 36) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 36 results.
Drug Design and Discovery|July 1, 1992
Tricyclic heteroaromatic systems. Synthesis and benzodiazepine binding activity of 1-substituted-3-methyl- and 3-phenylpyrazolo[4,5-c]quinolin-4-onesV Colotta, L Cecchi, F Melani, et al.
Farmaco (Societa Chimica Italiana : 1989)|June 26, 1998
Synthesis and A1 and A2A adenosine binding activity of some pyrano[2,3-c]pyrazol-4-onesV Colotta, D Catarzi, F Varano, et al.
Neuropharmacology|January 29, 2026
The potent and selective adenosine A<sub>2A</sub>R antagonists P400 and P625 protect against symptoms in autoimmune experimental encephalomyelitis by attenuating neuroinflammation and demyelinationM Morozzi, V Borgonetti, C Sasia, et al.
Journal of Chemical Information and Modeling|August 29, 2007
Tandem 3D-QSARs approach as a valuable tool to predict binding affinity data: design of new Gly/NMDA receptor antagonists as a key studyM Bacilieri, F Varano, F Deflorian, et al.
Journal of Cellular and Molecular Medicine|November 18, 2025
Protection From Demyelination by the Novel Adenosine Dual A<sub>2A</sub>/A<sub>2B</sub> Receptor Antagonist P626 in EAE and Cultured Oligodendrocyte Precursor CellsM Morozzi, F Cherchi, C Sasia, et al.
Neuropharmacology|October 20, 2025
Adenosine A<sub>2A</sub> receptor blockade promotes oligodendrocyte differentiation and myelination: Highlighting the potency of an edaravone-conjugated A<sub>2A</sub> receptor antagonistF Cherchi, L Frulloni, M Venturini, et al.
Pageof 4